Literature DB >> 21328511

From conventional to unusual enzyme inhibitor scaffolds: the quest for target specificity.

Eric Meggers1.   

Abstract

The tremendous challenge presented by the specific molecular recognition of single biomacromolecular targets within complex biological systems demands novel and creative design strategies. This Minireview discusses some conventional and unusual approaches for the design of target-selective enzyme inhibitors with a focus on the underlying chemical scaffolds. These include complicated natural-product-like organic molecules, stable octahedral metal complexes, fullerenes, carboranes, polymetallic clusters, and even polymers. Thus the whole repertoire of organic, inorganic, and macromolecular chemistry can be applied to tackle the problem of target-specific enzyme inhibition.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328511     DOI: 10.1002/anie.201005673

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  17 in total

1.  Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.

Authors:  Sandra Codony; Elena Valverde; Rosana Leiva; José Brea; M Isabel Loza; Christophe Morisseau; Bruce D Hammock; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2019-08-26       Impact factor: 3.641

2.  Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.

Authors:  Li Feng; Yann Geisselbrecht; Sebastian Blanck; Alexander Wilbuer; G Ekin Atilla-Gokcumen; Panagis Filippakopoulos; Katja Kräling; Mehmet Ali Celik; Klaus Harms; Jasna Maksimoska; Ronen Marmorstein; Gernot Frenking; Stefan Knapp; Lars-Oliver Essen; Eric Meggers
Journal:  J Am Chem Soc       Date:  2011-03-29       Impact factor: 15.419

3.  An organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanosine triphosphatase.

Authors:  Manuel Streib; Katja Kräling; Kristin Richter; Xiulan Xie; Holger Steuber; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-20       Impact factor: 15.336

4.  Classification of Metal-based Drugs According to Their Mechanisms of Action.

Authors:  Eszter Boros; Paul J Dyson; Gilles Gasser
Journal:  Chem       Date:  2019-11-07       Impact factor: 22.804

5.  Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Authors:  Lisa M Manus; Robert J Holbrook; Tulay A Atesin; Marie C Heffern; Allison S Harney; Amanda L Eckermann; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-01-02       Impact factor: 5.165

6.  Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process.

Authors:  L Brescacin; A Masi; G Sava; A Bergamo
Journal:  J Biol Inorg Chem       Date:  2015-09-14       Impact factor: 3.358

7.  Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.

Authors:  Jacob Fernández-Gallardo; Benelita T Elie; Florian J Sulzmaier; Mercedes Sanaú; Joe W Ramos; María Contel
Journal:  Organometallics       Date:  2014-10-30       Impact factor: 3.876

8.  Metal-conjugated affinity labels: a new concept to create enantioselective artificial metalloenzymes.

Authors:  Thomas Reiner; Dominik Jantke; Alexander N Marziale; Andreas Raba; Jörg Eppinger
Journal:  ChemistryOpen       Date:  2013-02-20       Impact factor: 2.911

9.  Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes.

Authors:  Lihua Lu; Hai-Jing Zhong; Modi Wang; See-Lok Ho; Hung-Wing Li; Chung-Hang Leung; Dik-Lung Ma
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

10.  Non-ATP-Mimetic Organometallic Protein Kinase Inhibitor.

Authors:  Kathrin Wähler; Katja Kräling; Holger Steuber; Eric Meggers
Journal:  ChemistryOpen       Date:  2013-09-05       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.